{"disease":{"id":"inherited-metabolic-disorders-imd","name":"inherited metabolic disorders imd"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04528355","title":"Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC","phase":"","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Paul Szabolcs","has_results":false},{"nct_id":"NCT03406962","title":"MGTA-456 in Patients With Inherited Metabolic Disorders Undergoing Hematopoietic Stem Cell Transplantation (HSCT)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":8,"lead_sponsor_name":"Magenta Therapeutics, Inc.","has_results":true},{"nct_id":"NCT04008849","title":"A Follow-up Study in Patients With Inherited Metabolic Disorders (IMD) Who Underwent Hematopoietic Stem Cell Transplantation (HSCT) With MGTA-456","phase":"","overall_status":"TERMINATED","enrollment_count":3,"lead_sponsor_name":"Magenta Therapeutics, Inc.","has_results":false},{"nct_id":"NCT02715505","title":"Safety and Exploratory Efficacy of HSC835 in Patients With Inherited Metabolic Disorders (IMD)","phase":"PHASE1, PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}